JP Patent

JP3040486B2 — キナゾリン誘導体，その製法及び抗癌作用を得るためのそれを含有する医薬品

Assigned to ゼネカ リミテッド · Expires 2000-05-15 · 26y expired

What this patent protects

Patent listed against lenvatinib-mesylate.

Drugs covered by this patent

Patent Metadata

Patent number
JP3040486B2
Jurisdiction
JP
Classification
—
Expires
2000-05-15
Drug substance claim
No
Drug product claim
No
Assignee
ゼネカ リミテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.